Cellectis (CLLS) Tops Q4 EPS by 58c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.02), $0.58 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $17.32 million versus the consensus estimate of $18.58 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target